Editor-in-Chief |
Highlights |
- Efficacy of Frontline Chemotherapy for Extranodal Natural Killer/T-Cell Lymphoma: A Systematic Review and Network Meta-Analysis
Treatment with non-anthracycline (ANT)-based chemotherapy has increased survival in patients with extranodal natural killer/T-cell lymphoma (ENKTCL). However, the relative efficacy of various drug combinations has been contentious.
Read More >> - Harnessing the Immune System: An Effective Way to Manage Diffuse Large B-Cell Lymphoma
Diffuse large B-cell lymphoma (DLBCL) is a heterogenous hematological disorder with malignant potential controlled by immunological characteristics of the tumor microenvironment. Rapid breakthrough in the molecular pathways has made immunological approaches the main anchor in the management of DLBCL, with or without chemotherapeutic agents.
Read More >> - Incidence and Risk of Hematological Adverse Events Associated With Immune Checkpoint Inhibitors: A Systematic Literature Review and Meta-Analysis
Immune checkpoint inhibitors (ICIs) have been a breakthrough in cancer therapy. ICI therapy is generally better tolerated than cytotoxic chemotherapy; however, hematological adverse events (AEs) have not been fully analyzed.
Read More >> - Mature Type T-Lymphoblastic Leukemia/Lymphoma Presenting With Isolated Central Nervous System Symptomatology in a Patient With Giant Cell Arteritis on Long-Term Steroid Treatment
T-lymphoblastic leukemia/lymphoma (T-ALL/T-LBL) is a malignancy comprised of T-lymphoblasts that can present as one of four clinical subtypes (pro-T, pre-T, cortical T, and mature T).
Read More >> - Acute Myeloid Leukemia Following Myeloproliferative Neoplasms: A Review of What We Know, What We Do Not Know, and Emerging Treatment Strategies
Acute myeloid leukemia (AML) arising from myeloproliferative neoplasms (MPNs) represents a small subtype of secondary AML (sAML). This entity is well known to be associated with poor responses to available treatment options and dismal outcomes.
Read More >>
Featured |
|
| Featured |
|
Real-World Data of Crizanlizumab in Sickle Cell Disease: A Single-Center Analysis | Local and Systemic Immunity During Five Vaccinations Against SARS-CoV-2 in Zanubrutinib-Treated Patients With Chronic Lymphocytic Leukemia |
Key Clinical Image |
Sickle Cell Trait: Is It Always Benign? |
Current Issue |
|
Vol. 13, No. 1-2, Apr 2024
Table of Contents
Review
Anorectal Infections in Neutropenic Leukemia Patients: A Common Clinical Challenge | Abstract HTML PDF |
Rodrick Babakhanlou, Farhad Ravandi-Kashani, Angel G. Hita, Dimitrios P. Kontoyiannis | 1-11 |
doi: https://doi.org/10.14740/jh1251 |
Original Article
Effective Management of Polycythemia Vera With Ropeginterferon Alfa-2b Treatment | Abstract HTML PDF |
Shan Shan Suo, Rong Feng Fu, Albert Qin, Zong Hong Shao, Jie Bai, Su Ning Chen, Ming Hui Duan, Hu Zhou, Na Xu, Su Jiang Zhang, Xue Lan Zuo, Xin Du, Li Wang, Pei Li, Xu Han Zhang, Dao Xiang Wu, Ya Ning Li, Jing Jing Zhang, Wei Wang, Wei Hong Shen, Oleh Zagrijtschuk, Toshiaki Sato, Zhi Jian Xiao, Jie Jin | 12-22 |
doi: https://doi.org/10.14740/jh1245 |
Natural Anticoagulant Protein Levels in Patients With Beta-Thalassemia Major: A Case-Control Study | Abstract HTML PDF |
Abbas Ahmadi, Soudabeh Hosseini, Akbar Dorgalaleh, Saeed Hassani, Shadi Tabibian, Behnaz Tavasoli, Ashkan Shabannezhad, Mahdi Taheri, Mahmood Shams | 23-28 |
doi: https://doi.org/10.14740/jh1217 |
Case Report
Hepatosplenic Alpha-Beta T-Cell Lymphoma: A Challenging Diagnostic Entity | Abstract HTML PDF |
Abanoub Gabra, Joanna Polanco, Shrija Thapa, Sumit Sawhney, Alexey Glazyrin | 29-33 |
doi: https://doi.org/10.14740/jh1203 |
Successful Treatment of Refractory Post-Transplant Lymphoproliferative Disorder With Chimeric Antigen Receptor T-Cell Therapy in a Heart Transplant Recipient | Abstract HTML PDF |
Katherine Hickmann, Ryan Sweeney, Chelsea Peterson, Kathleen Faringer, Madeline Riley, Mark Bunker, Azam Hadi, Cyrus Khan, Yazan Samhouri | 34-38 |
doi: https://doi.org/10.14740/jh1211 |
Middle Meningeal Artery Embolization in Acute Leukemia Patients Presenting With Subdural Hematoma | Abstract HTML PDF Suppl1 |
Binoy Yohannan, Juan Carlos Martinez Gutierrez, Peng Roc Chen, Adan Rios | 39-45 |
doi: https://doi.org/10.14740/jh1215 |
Clinical Efficacy of Programmed Cell Death Ligand 1 Antibody in Treatment of Extranodal Natural Killer/T-Cell Lymphoma With Hemophagocytic Lymphohistiocytosis | Abstract HTML PDF |
Chun Li Yang, Xi Chen, Hui Jie Zhou, Wan Chun Wu, Li Qun Zou | 46-51 |
doi: https://doi.org/10.14740/jh1242 |